Drug
Pac-14028 clinical trials
Also written PAC-14028.
- studies test it
- 12
- open now
- 0
- in phase 3
- 1
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
12 studies that test it; most in 2014 (4)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 8
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Studies
Open first, then newest update. How each study uses pac-14028 is read from its arms, and is right about nine times in ten.
Testing it · 12
- CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic DermatitisCompletedPhase 3Amorepacific CorporationNCT02965118Written as PAC-14028 cream 1.0%
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic DermatitisCompletedPhase 1/2Amorepacific CorporationNCT02748993Written as PAC-14028 Cream 0.1%
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic DermatitisCompletedPhase 2Amorepacific CorporationNCT02757729Written as PAC-14028 cream 0.1%
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in RosaceaCompletedPhase 2Amorepacific CorporationNCT02583009Written as PAC-14028 cream 0.1%
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin PruritusCompletedPhase 2Amorepacific CorporationNCT02565134Written as PAC-14028 cream 0.1%
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic DermatitisCompletedPhase 2Amorepacific CorporationNCT02749383Written as PAC-14028 cream 0.3%
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male SubjectsCompletedPhase 1Amorepacific CorporationNCT02309008Written as PAC-14028
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic DermatitisCompletedPhase 2Amorepacific CorporationNCT02583022Written as PAC-14028 cream 1.0%
- Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin PruritusCompletedPhase 2Amorepacific CorporationNCT02052531Written as PAC-14028
- Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea PatientsCompletedPhase 2Amorepacific CorporationNCT02052999Written as PAC-14028 cream 1%
- PAC-14028 in Healthy Male VolunteersCompletedPhase 1Amorepacific CorporationNCT01264224Written as PAC-14028
- Cumulative Irritation Test of PAC-14028 in Healthy VolunteersCompletedPhase 1Amorepacific CorporationNCT01638117Written as PAC14028-0.1
Codes
What other systems call pac-14028 · ClinicalTrials.gg INT005865
- UNII (FDA) 3VF7K7Z10BASIVATREPConfirmed FDA, Wikidata
- Wikidata Q27258085pac-14028Confirmed FDA, Wikidata
- DrugBank DB12428One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 3VF7K7Z10B | ASIVATREP | Confirmed FDA, Wikidata |
| Wikidata | Q27258085 | pac-14028 | Confirmed FDA, Wikidata |
| DrugBank | DB12428 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.